• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

1999 Fiscal Year Final Research Report Summary

Matrix metalloproteinases in chronic liver diseases and hepatocellular carcinoma.

Research Project

Project/Area Number 09670550
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionTottori University

Principal Investigator

MURAWAKI Yoshikazu  Tottori University Hospital, 2nd Dept Intern Med, Assistant professor, 医学部附属病院, 講師 (90144659)

Project Period (FY) 1997 – 1999
KeywordsMMP-1 / MMP-2 / MMP-3 / MMP-9 / LIVER DISEASE
Research Abstract

To elucidate the clinical usefulness of serum matrix metalloproteinase (MMP)-1, MMP-2, MMP-3 and MMP-9 in chronic liver disease and hepatocellular carcinoma, we measured these enzyme concentrations in serum and liver, and compared the results with clinicopathological findings.
(1)Serum MMP-1 concentration decreased during histological progression of chronic hepatitis. The serum MMP-1 test was useful clinically to differentiate active and inactive types of hepatitis in patients with chronic viral hepatitis.
(2)The serum MMP-2 concentration refects mainly the amount of proMMP-2 complexed with TIMP-2. The serum MMP-2 level was markedly increased in cirrhotic patients, and may be explained by an overproduction in the cirrhotic liver. In the clinical state, the measurement of serum MMP-2 was as useful a test for diagnosing liver cirrhosis as the serum hyaluronan test.
(3)The plasma MMP-9 level, as well as the MMP-2 level, was significantly increased in cirrhotic patients, probably due to overproduction in the cirrhotic liver. However, the plasma MMP-9 test was inferior to the plasma MMP-2 test for the diagnosis of cirrhosis.
(4)The serum MMP-3 concentration was about 2-fold higher in the males than in the females, and 55% lower in chronic hepatitis, 53% lower in liver cirrhosis and 46% lower in hepatocellular carcinoma. The MMP-3 concentration in the cirrhotic liver was quite similar to that in the non-cirrhotic liver. The measurement of serum MMP-3 was of little use for assessing fibrolysis in chronically diseased livers.

  • Research Products

    (12 results)

All Other

All Publications (12 results)

  • [Publications] Yoshikazu Murawaki: "Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis"J. Gastroenterol. Hepatol.. 14. 138-145 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshikazu Murawaki: "Clinical usefulness of serum matrix metalloproteniase-2 concentration in patients with chronic viral liver disease"J. Hepatol.. 30. 1090-1098 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshikazu Murawaki: "Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chromic liver disease"J. Hepatol.. 31. 474-481 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshikazu Murawaki: "Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chromic liver disease in comparison with serum TIMP-1"Clin. Chim. Acta.. 281. 109-120 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshikazu Murawaki: "Plasma transforming growth factor-β1 concentrations in patients with chronic viral hepatitis"J. Gastroenterol. Hepatol.. 13. 680-684 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 村脇 義和: "肝線維化マーカー"肝胆膵B:. 37. 375-386 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yoshikazu Murawaki: "Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis"J Gastroenterol Hepatol. 14. 138-145 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikazu Murawaki: "Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease"J Hepatol. 30. 1090-1098 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikazu Murawaki: "Serum matrix metalloproteinase-3 (stromelysin-1) concentration in patients with chronic liver disease"J Hepatol. 31. 474-481 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikazu Murawaki: "Clinical usefulness of serum tissue inhibitor of metalloproteinases (TIMP)-2 assay in patients with chronic liver disease in comparison with serum TIMP-1"Clin Chim Acta. 281. 109-120 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikazu Murawaki: "Plasma transforming growth factor-betal concentration in patients with chronic viral hepatitis"J Gastroenterol Hepatol. 13. 680-684 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yoshikazu Murawaki: "Serum fibrotic markers in chronic liver disease. (Japanese)"KanTanSui. 37. 375-386 (1998)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2001-10-23  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi